• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵磷脂胆固醇酰基转移酶的正变构调节剂可调整膜结合结构域的方向并改变其空间自由能分布。

Positive allosteric modulators of lecithin: Cholesterol acyltransferase adjust the orientation of the membrane-binding domain and alter its spatial free energy profile.

作者信息

Niemelä Akseli, Koivuniemi Artturi

机构信息

Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.

出版信息

PLoS Comput Biol. 2021 Mar 15;17(3):e1008426. doi: 10.1371/journal.pcbi.1008426. eCollection 2021 Mar.

DOI:10.1371/journal.pcbi.1008426
PMID:33720934
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7993845/
Abstract

Lecithin:cholesterol acyltransferase protein (LCAT) promotes the esterification reaction between cholesterol and phospholipid-derived acyl chains. Positive allosteric modulators have been developed to treat LCAT deficiencies and, plausibly, also cardiovascular diseases in the future. The mechanism of action of these compounds is poorly understood. Here computational docking and atomistic molecular dynamics simulations were utilized to study the interactions between LCAT and the activating compounds. Results indicate that all drugs bind to the allosteric binding pocket in the membrane-binding domain in a similar fashion. The presence of the compounds in the allosteric site results in a distinct spatial orientation and sampling of the membrane-binding domain (MBD). The MBD's different spatial arrangement plausibly affects the lid's movement from closed to open state and vice versa, as suggested by steered molecular dynamics simulations.

摘要

卵磷脂胆固醇酰基转移酶蛋白(LCAT)促进胆固醇与磷脂衍生的酰基链之间的酯化反应。已经开发出正变构调节剂来治疗LCAT缺乏症,并且有望在未来也用于治疗心血管疾病。这些化合物的作用机制尚不清楚。在这里,利用计算对接和原子分子动力学模拟来研究LCAT与激活化合物之间的相互作用。结果表明,所有药物都以类似的方式结合到膜结合结构域的变构结合口袋中。变构位点中化合物的存在导致膜结合结构域(MBD)的独特空间取向和取样。正如引导分子动力学模拟所表明的,MBD不同的空间排列可能会影响盖子从关闭状态到打开状态的移动,反之亦然。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2288/7993845/e5c605029ce9/pcbi.1008426.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2288/7993845/42f87fb1ca25/pcbi.1008426.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2288/7993845/3b310401e26d/pcbi.1008426.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2288/7993845/46f855b306c2/pcbi.1008426.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2288/7993845/1d9cf5372e22/pcbi.1008426.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2288/7993845/f3c85a3cbab0/pcbi.1008426.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2288/7993845/e5c605029ce9/pcbi.1008426.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2288/7993845/42f87fb1ca25/pcbi.1008426.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2288/7993845/3b310401e26d/pcbi.1008426.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2288/7993845/46f855b306c2/pcbi.1008426.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2288/7993845/1d9cf5372e22/pcbi.1008426.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2288/7993845/f3c85a3cbab0/pcbi.1008426.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2288/7993845/e5c605029ce9/pcbi.1008426.g006.jpg

相似文献

1
Positive allosteric modulators of lecithin: Cholesterol acyltransferase adjust the orientation of the membrane-binding domain and alter its spatial free energy profile.卵磷脂胆固醇酰基转移酶的正变构调节剂可调整膜结合结构域的方向并改变其空间自由能分布。
PLoS Comput Biol. 2021 Mar 15;17(3):e1008426. doi: 10.1371/journal.pcbi.1008426. eCollection 2021 Mar.
2
Mechanistic Insights into the Activation of Lecithin-Cholesterol Acyltransferase in Therapeutic Nanodiscs Composed of Apolipoprotein A-I Mimetic Peptides and Phospholipids.治疗性纳米盘组成的载脂蛋白 A-I 模拟肽和磷脂中卵磷脂胆固醇酰基转移酶的激活机制研究
Mol Pharm. 2022 Nov 7;19(11):4135-4148. doi: 10.1021/acs.molpharmaceut.2c00540. Epub 2022 Sep 16.
3
Arginine 123 of apolipoprotein A-I is essential for lecithin:cholesterol acyltransferase activity.载脂蛋白 A-I 第 123 位精氨酸对于卵磷脂胆固醇脂酰转移酶活性是必需的。
J Lipid Res. 2018 Feb;59(2):348-356. doi: 10.1194/jlr.M080986. Epub 2017 Dec 5.
4
Rescue of Familial Lecithin:Cholesterol Acyltranferase Deficiency Mutations with an Allosteric Activator.家族性卵磷脂:胆固醇酰基转移酶缺乏突变的变构激活剂拯救。
Mol Pharmacol. 2024 Sep 17;106(4):188-197. doi: 10.1124/molpharm.124.000932.
5
Role of the interfacial binding domain in the oxidative susceptibility of lecithin:cholesterol acyltransferase.界面结合结构域在卵磷脂胆固醇酰基转移酶氧化敏感性中的作用。
Biochem J. 2002 Aug 1;365(Pt 3):649-57. doi: 10.1042/BJ20020064.
6
Advances in understanding of the role of lecithin cholesterol acyltransferase (LCAT) in cholesterol transport.对卵磷脂胆固醇酰基转移酶(LCAT)在胆固醇转运中作用的认识进展。
Clin Chim Acta. 1999 Aug;286(1-2):257-71. doi: 10.1016/s0009-8981(99)00106-0.
7
Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesterol.增加高密度脂蛋白胆固醇的化合物激活卵磷脂胆固醇酰基转移酶的分子基础。
Elife. 2018 Nov 27;7:e41604. doi: 10.7554/eLife.41604.
8
Regiospecific esterification of estrogens by lecithin:cholesterol acyltransferase.卵磷脂:胆固醇酰基转移酶对雌激素的区域特异性酯化作用。
J Clin Endocrinol Metab. 1999 Jul;84(7):2481-8. doi: 10.1210/jcem.84.7.5755.
9
Role of glutamic acid residues 154, 155, and 165 of lecithin:cholesterol acyltransferase in cholesterol esterification and phospholipase A2 activities.卵磷脂:胆固醇酰基转移酶的谷氨酸残基154、155和165在胆固醇酯化及磷脂酶A2活性中的作用
J Lipid Res. 1998 Jan;39(1):51-8.
10
A comparison of the esterification of steroids by rat lecithin:cholesterol acyltransferase and acyl coenzyme A:cholesterol acyltransferase.大鼠卵磷脂:胆固醇酰基转移酶和酰基辅酶A:胆固醇酰基转移酶对类固醇酯化作用的比较。
Endocrinology. 1995 Jan;136(1):180-6. doi: 10.1210/endo.136.1.7828529.

引用本文的文献

1
How residence time works in allosteric drugs.变构药物中的驻留时间是如何起作用的。
Curr Opin Struct Biol. 2025 Aug 29;94:103149. doi: 10.1016/j.sbi.2025.103149.
2
Gliflozins, sucrose and flavonoids are allosteric activators of lecithin-cholesterol acyltransferase.格列净类、蔗糖和类黄酮都是卵磷脂胆固醇脂酰转移酶的别构激活剂。
Sci Rep. 2024 Oct 30;14(1):26085. doi: 10.1038/s41598-024-77104-3.
3
Rescue of Familial Lecithin:Cholesterol Acyltranferase Deficiency Mutations with an Allosteric Activator.家族性卵磷脂:胆固醇酰基转移酶缺乏突变的变构激活剂拯救。

本文引用的文献

1
Novel lecithin: cholesterol acyltransferase-based therapeutic approaches.新型卵磷脂:胆固醇酰基转移酶为基础的治疗方法。
Curr Opin Lipidol. 2020 Apr;31(2):71-79. doi: 10.1097/MOL.0000000000000673.
2
Structural analysis of lecithin:cholesterol acyltransferase bound to high density lipoprotein particles.结合态高密度脂蛋白中卵磷脂胆固醇脂酰转移酶的结构分析。
Commun Biol. 2020 Jan 15;3(1):28. doi: 10.1038/s42003-019-0749-z.
3
Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesterol.
Mol Pharmacol. 2024 Sep 17;106(4):188-197. doi: 10.1124/molpharm.124.000932.
4
Mechanistic Insights into the Activation of Lecithin-Cholesterol Acyltransferase in Therapeutic Nanodiscs Composed of Apolipoprotein A-I Mimetic Peptides and Phospholipids.治疗性纳米盘组成的载脂蛋白 A-I 模拟肽和磷脂中卵磷脂胆固醇酰基转移酶的激活机制研究
Mol Pharm. 2022 Nov 7;19(11):4135-4148. doi: 10.1021/acs.molpharmaceut.2c00540. Epub 2022 Sep 16.
增加高密度脂蛋白胆固醇的化合物激活卵磷脂胆固醇酰基转移酶的分子基础。
Elife. 2018 Nov 27;7:e41604. doi: 10.7554/eLife.41604.
4
Cholesterol is Inefficiently Converted to Cholesteryl Esters in the Blood of Cardiovascular Disease Patients.心血管疾病患者的血液中胆固醇转化为胆固醇酯的效率较低。
Sci Rep. 2018 Oct 3;8(1):14764. doi: 10.1038/s41598-018-33116-4.
5
Interaction of lecithin:cholesterol acyltransferase with lipid surfaces and apolipoprotein A-I-derived peptides.卵磷脂:胆固醇酰基转移酶与脂质表面和载脂蛋白 A-I 衍生肽的相互作用。
J Lipid Res. 2018 Apr;59(4):670-683. doi: 10.1194/jlr.M082685. Epub 2018 Feb 8.
6
A retractable lid in lecithin:cholesterol acyltransferase provides a structural mechanism for activation by apolipoprotein A-I.卵磷脂胆固醇酰基转移酶中的一个可伸缩盖子为载脂蛋白A-I的激活提供了一种结构机制。
J Biol Chem. 2017 Dec 8;292(49):20313-20327. doi: 10.1074/jbc.M117.802736. Epub 2017 Oct 13.
7
Lecithin:Cholesterol Acyltransferase Activation by Sulfhydryl-Reactive Small Molecules: Role of Cysteine-31.卵磷脂:巯基反应性小分子激活胆固醇酰基转移酶:半胱氨酸-31的作用
J Pharmacol Exp Ther. 2017 Aug;362(2):306-318. doi: 10.1124/jpet.117.240457. Epub 2017 Jun 2.
8
Agonistic Human Antibodies Binding to Lecithin-Cholesterol Acyltransferase Modulate High Density Lipoprotein Metabolism.与卵磷脂胆固醇酰基转移酶结合的激动型人抗体调节高密度脂蛋白代谢。
J Biol Chem. 2016 Feb 5;291(6):2799-811. doi: 10.1074/jbc.M115.672790. Epub 2015 Dec 7.
9
Safety and Tolerability of ACP-501, a Recombinant Human Lecithin:Cholesterol Acyltransferase, in a Phase 1 Single-Dose Escalation Study.重组人卵磷脂:胆固醇酰基转移酶ACP-501在1期单剂量递增研究中的安全性和耐受性
Circ Res. 2016 Jan 8;118(1):73-82. doi: 10.1161/CIRCRESAHA.115.306223. Epub 2015 Dec 1.
10
HDL and cardiovascular disease.高密度脂蛋白与心血管疾病。
Lancet. 2014 Aug 16;384(9943):618-625. doi: 10.1016/S0140-6736(14)61217-4.